Esperion Therapeutics Inc. (NASDAQ: ESPR)’s Downward Trend Continues

The trading price of Esperion Therapeutics Inc. (NASDAQ:ESPR) closed lower on Monday, April 22, closing at $1.91, -2.05% lower than its previous close.

In examining the 52-week price action we see that the stock hit a 52-week high of $3.40 and a 52-week low of $0.70. Over the past month, the stock has lost -9.48% in value.

Esperion Therapeutics Inc., whose market valuation is $325.50 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Esperion Therapeutics Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ESPR has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.

A quick review shows that ESPR’s price is currently -24.12% off the SMA20 and -22.34% off the SMA50. The RSI metric on the 14-day chart is currently showing 36.07, and weekly volatility stands at 10.17%. When measured over the past 30 days, the indicator reaches 12.80%. Esperion Therapeutics Inc. (NASDAQ:ESPR)’s beta value is currently sitting at 0.90, while the Average True Range indicator is currently displaying 0.27.

To see how Esperion Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ESPR stock’s performance was -2.05% in the latest trading, and 49.22% in the past year.

An evaluation of the daily trading volume of Esperion Therapeutics Inc. (NASDAQ:ESPR) indicates that the 3-month average is 6.33 million.

Currently, records show that 170.42 million of the company’s shares remain outstanding. The insiders hold 1.10% of outstanding shares, whereas institutions hold 48.26%. However, since the stock’s price has seen -36.12% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.

Most Popular